Leqembi: Side Effects and How to Manage Them

Medical note: This article is for educational purposes only and is not a substitute for medical advice. Leqembi can cause serious side effects, so patients and caregivers should always follow the treatment team’s instructions and report new or worsening symptoms right away.

Leqembi, also known by its generic name lecanemab-irmb, is one of the most talked-about Alzheimer’s disease treatments in the United States. It belongs to a class of medicines called anti-amyloid monoclonal antibodies, which are designed to target amyloid plaques in the brain. In plain English: Leqembi is not trying to make lost car keys magically reappear, but it may help slow disease progression in certain people with early Alzheimer’s disease.

That said, Leqembi is not a casual “take it and forget it” medication. It requires careful screening, regular monitoring, brain MRI scans, and a treatment team that knows how to watch for side effects. Some side effects are mild and manageable. Others, especially amyloid-related imaging abnormalities, need prompt medical attention. This guide explains the most important Leqembi side effects, what they may feel like, and how patients and caregivers can manage them safely.

What Is Leqembi Used For?

Leqembi is approved for certain adults with early Alzheimer’s disease, including people with mild cognitive impairment or mild dementia due to Alzheimer’s. Before treatment begins, doctors typically confirm the presence of amyloid pathology through appropriate testing. That matters because Leqembi is aimed at amyloid, not every possible cause of memory loss.

Think of it like hiring a specialist plumber. If the problem is a leaky pipe, great. If the problem is the roof, the plumber is going to look very confused. In the same way, Leqembi is intended for a specific type and stage of Alzheimer’s disease, not for all forms of dementia or memory trouble.

Common Leqembi Side Effects

The most commonly reported side effects of Leqembi include infusion-related reactions, amyloid-related imaging abnormalities, often called ARIA, and headache. Some patients may also experience dizziness, nausea, fatigue, falls, injection-site reactions with certain maintenance formulations, or symptoms that overlap with other health conditions.

The tricky part is that side effects do not always arrive wearing a name tag. A headache could be simple. It could also be a warning sign. A brief chill during an infusion may be manageable. Shortness of breath or swelling of the face is a much bigger deal. This is why Leqembi treatment is built around monitoring, communication, and fast reporting of unusual symptoms.

ARIA: The Side Effect Everyone Should Understand

What Is ARIA?

ARIA stands for amyloid-related imaging abnormalities. It is one of the most important safety concerns with Leqembi and other anti-amyloid treatments. ARIA may involve temporary swelling or fluid buildup in areas of the brain, called ARIA-E, or small areas of bleeding or iron deposits, called ARIA-H.

Many ARIA cases do not cause symptoms and are found only on MRI scans. That sounds oddly polite for a serious side effect, but “silent” does not mean “ignore it.” In some cases, ARIA can cause symptoms and may become serious or even life-threatening. That is why doctors schedule brain MRI scans before and during treatment.

Possible ARIA Symptoms

Patients and caregivers should contact the healthcare team right away if symptoms appear during Leqembi treatment. Possible ARIA-related symptoms include headache, confusion, dizziness, vision changes, nausea, trouble walking, weakness, or seizures. Any sudden neurological symptom deserves immediate medical attention. This is not the moment to say, “Let’s see how it looks after lunch.”

Who Has a Higher Risk of ARIA?

ARIA risk may be higher in people who carry two copies of the APOE e4 gene, a genetic factor linked with Alzheimer’s risk. Doctors may discuss genetic testing before treatment, but the decision is personal and should include counseling about what the result can and cannot tell you.

People taking blood thinners or medications that affect bleeding risk may also need extra caution. This does not automatically mean Leqembi is impossible, but it does mean the treatment team must carefully review medications, stroke history, MRI findings, and overall risk before moving forward.

How ARIA Is Managed

ARIA management depends on the MRI findings, symptom severity, and the patient’s overall health. Mild ARIA without symptoms may be monitored closely. More serious or symptomatic ARIA may require pausing treatment, repeating MRI scans, or stopping Leqembi. The key rule is simple: do not try to manage possible ARIA at home with guesswork, optimism, or a search engine rabbit hole at 2 a.m.

Infusion-Related Reactions

Leqembi is commonly given by intravenous infusion during the initial treatment period. Infusion-related reactions can happen during or shortly after the infusion. Symptoms may include fever, chills, body aches, nausea, vomiting, dizziness, changes in blood pressure, fast heartbeat, shortness of breath, or feeling shaky.

These reactions are one reason infusions are given in a healthcare setting. Nurses and doctors can monitor patients, slow or stop the infusion if needed, and provide medications to treat symptoms. Patients should tell the infusion team immediately if something feels off. This is not a “be brave and power through” situation. The infusion chair is not a roller coaster; you are allowed to speak up.

How to Manage Infusion Reactions

Before the infusion, patients should arrive hydrated unless their doctor has given fluid restrictions. They should bring a complete medication list and mention any previous infusion reactions, allergies, asthma, heart problems, or recent illness. During the infusion, reporting symptoms early can help the care team respond before a reaction becomes more severe.

For patients who have had prior reactions, doctors may consider preventive steps such as adjusting the infusion rate or using premedication. The exact plan should come from the prescribing clinician, not from a neighbor who once watched half a medical drama and now owns a blood pressure cuff.

Headache, Dizziness, and Nausea

Headache is one of the common Leqembi side effects. Dizziness and nausea may also occur. These symptoms can be mild, but they deserve attention because they may overlap with ARIA symptoms. The safest approach is to track when the symptom started, how severe it is, whether it is getting worse, and whether it comes with confusion, vision changes, weakness, or balance problems.

For mild symptoms, the healthcare team may recommend rest, hydration, or approved over-the-counter options. However, patients should not start pain relievers or nausea medications without checking first, especially if they take blood thinners or have kidney, liver, stomach, or heart conditions.

Serious Allergic Reactions

Leqembi can cause serious allergic reactions. Warning signs may include swelling of the face, lips, mouth, tongue, or throat; hives; rash; itching; wheezing; trouble breathing; chest tightness; dizziness; or fainting. These symptoms need urgent medical care.

Allergic reactions are rare compared with more common side effects, but they can escalate quickly. Patients should tell the care team about past reactions to medications, biologic therapies, or infusions. Caregivers should also know what symptoms require emergency help because, in real life, the person having the reaction may not be the best person to calmly organize the response.

Injection-Site Reactions With Maintenance Treatment

Some patients may use a subcutaneous maintenance version of Leqembi after completing an initial treatment period, depending on FDA-approved use and their clinician’s plan. Injection-site reactions can include redness, swelling, itching, bruising, warmth, pain, or a small collection of blood under the skin. Mild fever, fatigue, or headache may also occur.

Patients should follow the training provided by their healthcare team. They should not inject into irritated, bruised, scarred, or tender skin unless specifically instructed. Any severe swelling, spreading rash, breathing difficulty, or signs of infection should be reported promptly.

Why MRI Monitoring Matters

MRI scans are not just paperwork with a loud machine attached. They are one of the most important tools for detecting ARIA. Current U.S. prescribing information includes a baseline brain MRI before starting Leqembi and additional MRI monitoring during treatment, including scans before certain early infusions.

Patients should keep MRI appointments even if they feel fine. ARIA may not cause symptoms at first, and early detection can help doctors decide whether to continue, pause, or adjust treatment. Skipping monitoring is like driving with the dashboard covered because the warning lights make you nervous. Understandable? Maybe. Wise? Absolutely not.

What Patients Should Tell Their Doctor Before Starting Leqembi

Before treatment, patients should give their doctor a complete medical history. Important details include past strokes, seizures, brain bleeding, recent head injury, uncontrolled blood pressure, use of anticoagulants or antiplatelet medications, autoimmune conditions, allergies, and all prescription or over-the-counter medications.

Patients should also mention supplements. “Natural” does not automatically mean “risk-free,” especially when bleeding risk is part of the conversation. The treatment team needs the full picture, not the edited highlight reel.

Practical Ways to Manage Leqembi Side Effects

Keep a Symptom Journal

A simple notebook or phone note can be surprisingly powerful. Track infusion dates, MRI dates, headaches, dizziness, nausea, confusion, falls, sleep changes, and any unusual symptoms. Include the time symptoms started, how long they lasted, and what helped. This makes clinic visits more useful and reduces the classic problem of forgetting every symptom the moment the doctor asks, “So, how have you been?”

Create a Caregiver Alert Plan

Leqembi treatment often works best when caregivers are actively involved. Make a short list of symptoms that require a call to the doctor and symptoms that require emergency care. Keep the clinic number, infusion center number, medication list, and insurance information easy to find.

Do Not Ignore Falls

Falls can happen for many reasons in older adults and people with cognitive impairment. During Leqembi treatment, a fall should be reported, especially if it involves a head bump, confusion, weakness, or new headache. A “small fall” can still matter medically.

Ask About Medication Interactions

Because bleeding risk is an important safety concern, patients should ask before starting aspirin, blood thinners, anti-inflammatory pain relievers, or supplements that may affect bleeding. The goal is not to panic about every pill in the cabinet; the goal is to avoid surprises.

Know When to Seek Urgent Help

Seek urgent medical attention for severe headache, sudden confusion, seizure, new weakness, difficulty speaking, vision changes, trouble breathing, swelling of the face or throat, chest pain, fainting, or symptoms that feel sudden and unusual. When in doubt, contact the healthcare team immediately.

Leqembi Side Effects: A Caregiver’s Perspective

For caregivers, Leqembi can feel like a mix of hope, logistics, and a calendar that suddenly has more appointments than a celebrity dentist. There may be infusions, MRI scans, lab work, memory assessments, insurance steps, and follow-up visits. Side effect management is not only medical; it is organizational.

A caregiver may be the first person to notice that a patient is more confused than usual, walking differently, complaining of a new headache, or acting “not quite right.” Those observations matter. A brief note such as “more confused after breakfast, lasted two hours, no fever” can help the care team decide what to do next.

Caregivers should also protect their own energy. Alzheimer’s care is emotionally demanding, and treatment monitoring can add another layer. Keeping a folder, sharing responsibilities with family, using appointment reminders, and asking the clinic for clear written instructions can reduce stress. Nobody gets bonus points for doing everything alone while pretending it is easy.

Questions to Ask the Doctor About Leqembi Side Effects

Patients and caregivers may want to ask: What side effects should we report immediately? What MRI schedule will we follow? How does APOE e4 status affect risk? Are any current medications a concern? What should we do if a headache starts after an infusion? Who do we call after hours? What symptoms mean emergency care?

Good questions do not annoy good clinicians. They make treatment safer. If the answer sounds complicated, ask for it in writing. Medical instructions should not depend on memory alone, especially when memory is already part of the diagnosis.

500-Word Experience Section: What Managing Leqembi Side Effects Can Feel Like in Real Life

Real-world Leqembi treatment is rarely as neat as a brochure. A family may begin with cautious optimism: the neurologist explains the potential benefit, the risks, the MRI schedule, and the need for ongoing monitoring. Everyone nods. Then the actual calendar appears, and suddenly Tuesday morning has become “infusion day,” Thursday is “MRI paperwork day,” and someone has to remember where the parking garage ticket went.

One common experience is that the first infusion feels like the biggest emotional hurdle. The patient may be nervous, the caregiver may be quietly more nervous, and the infusion staff may become the calmest people in the room. Some patients feel fine afterward. Others may feel chilled, tired, achy, or headachy. When symptoms are mild, the care team may simply monitor and advise. But the important habit is reporting symptoms early, not waiting until the next appointment.

Another real-life challenge is telling normal aging, Alzheimer’s symptoms, and possible side effects apart. A patient with early Alzheimer’s may already have forgetfulness or occasional confusion. So when confusion worsens for a day, families may wonder: Is this the disease? Poor sleep? Dehydration? A medication reaction? ARIA? This uncertainty is exactly why symptom tracking is useful. Patterns help clinicians. A caregiver’s notes can turn a vague concern into actionable information.

MRI monitoring can also create anxiety. Some patients dislike the noise, the enclosed space, or the waiting period for results. Caregivers can help by scheduling scans at a time of day when the patient is usually calmer, bringing hearing protection if allowed, confirming transportation, and asking the imaging center what to expect. Small planning steps can make a big difference.

Families may also experience “side effect fatigue.” At first, everyone is alert to every headache, every stumble, every odd comment. Over time, that level of attention can feel exhausting. The solution is not to stop paying attention; it is to create a clear system. Know the red-flag symptoms. Know who to call. Keep the medication list updated. Use a simple checklist after infusions. This turns anxiety into routine.

There is also an emotional side. Leqembi may represent hope, but hope with fine print. Patients may feel frustrated by appointments or worried about serious risks. Caregivers may feel responsible for catching every possible warning sign. Honest conversations help. It is okay to say, “This is a lot.” It is okay to ask the clinic to repeat instructions. It is okay to request support from family members who are very good at saying, “Let me know if you need anything,” but mysteriously disappear when the calendar opens.

The best experience is usually built around teamwork: the patient, caregiver, neurologist, infusion staff, radiology team, primary care doctor, and pharmacist all sharing information. Leqembi side effects are most manageable when nobody is guessing alone.

Conclusion

Leqembi is an important treatment option for certain people with early Alzheimer’s disease, but it comes with meaningful safety responsibilities. The most important side effects to understand are ARIA, infusion-related reactions, headache, allergic reactions, and injection-site reactions when applicable. Managing these risks requires MRI monitoring, clear communication, careful medication review, and fast reporting of new symptoms.

For patients and caregivers, the goal is not to fear every possible side effect. The goal is to recognize warning signs, stay organized, and work closely with the healthcare team. Leqembi treatment is a serious journey, but with good monitoring and a practical plan, families can approach it with more confidence and fewer “Wait, were we supposed to call the doctor about that?” moments.